LABCORP HOLDINGS INC. — Director's Dealing 2020

Feb 14, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-12

Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-02-12	Common Stock	M	233	—	Acquired	533.3565	Direct
2020-02-12	Common Stock	F	64	$187.51	Disposed	469.3565	Direct
2020-02-12	Common Stock	M	283	—	Acquired	752.3565	Direct
2020-02-12	Common Stock	F	78	$187.51	Disposed	674.3565	Direct
2020-02-13	Common Stock	S	85	$188.49	Disposed	589.3565	Direct
2020-02-13	Common Stock	S	103	$188.49	Disposed	486.3565	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-02-12	Restricted Stock Unit	$	M	233	Disposed		Common Stock (233)	Direct
2020-02-12	Restricted Stock Unit	$	M	283	Disposed		Common Stock (283)	Direct

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.

F4: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.

F5: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F6: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.